IDEA TO DRUG
Dead / Cancelled — Cancelled — Section 8 (as of 17 Aug 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85321526
- Registration number
- 4083112
- Mark type
- Stylized text
- Filed
- 16 May 2011
- Published for opposition
- 25 Oct 2011
- Registered
- 10 Jan 2012
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 042 — Scientific and technological services: Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals
Owner
- TENIUM THERAPEUTICS, INC., LA JOLLA, CA, US
- INHIBRX, LP, LA JOLLA, CA, US
- Inhibrx, LLC, La Jolla, CA, US
- Inhibrx, LLC, La Jolla, CA, US
- Inhibrx, LLC, La Jolla, CA, US
Prosecution history
- 12 Sept 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 22 Aug 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 17 Aug 2018 — CANCELLED SEC. 8 (6-YR)
- 10 Jan 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Sept 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 10 Jan 2012 — REGISTERED-PRINCIPAL REGISTER
- 25 Oct 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Oct 2011 — PUBLISHED FOR OPPOSITION
- 21 Sept 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 20 Sept 2011 — ASSIGNED TO LIE
- 06 Sept 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Sept 2011 — EXAMINER'S AMENDMENT ENTERED
- 06 Sept 2011 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 06 Sept 2011 — EXAMINERS AMENDMENT E-MAILED
- 06 Sept 2011 — EXAMINERS AMENDMENT -WRITTEN